Stephan Müller
Posts by Stephan Müller:
Collaboration with the University of Zürich on membrane protein targeted sybodies
leadXpro AG and the University of Zurich (UZH) collaborate to generate sybodies as molecular discovery tools, therapeutic lead compounds and diagnostic reagents against disease-relevant membrane protein targets.
Collaboration with InterAx on new immune oncology drugs
leadXpro AG and InterAx Biotech AG, join forces to discover and optimize new drug lead molecules targeting G-protein coupled receptors.
Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals
The paper reports an efficient method to generate multiple co-structures of the A2A G protein-coupled receptor (GPCR) with small-molecules from a single preparation of a thermostabilised receptor crystallised in Lipidic Cubic Phase (LCP)
CTI grants leadXpro startup label
The Swiss Commission for Technology and Innovation CTI awards leadXpro the CTI startup label.
BASF and leadXpro announce research collaboration
BASF and leadXpro AG will join forces to collaborate on the structure-based discovery of new active ingredients by employing single particle cryo-electron microscopy.
leadXpro scientists chart the future of structure based drug discovery
leadXpro AG scientists explore the utility of cutting-edge X-ray technologies for the discovery of new therapeutics.
leadXpro adopts creoptix’ wave technology for ligand characterization
Creoptix and leadXpro AG announce the selection of the Creoptix WAVE technology by leadXpro to strengthen its capabilities for drug discovery aimed at identifying and optimizing drug candidates directed against challenging membrane protein drug targets.